WHO promises new global focus on hep C diagnostics
This article was originally published in Clinica
The World Health Organization (WHO) is to develop a "comprehensive approach to the prevention and control" of five types of viral hepatitis, promising an important focus on diagnostics. The plans were endorsed by the WHO's member states on 21 April, through a resolution that features a number of measures to improve healthcare and public awareness of the condition. Hepatitis A, B, C, D and E are thought to jointly account for over one million deaths per year, according to the WHO. "An estimated one in 12 people are infected with hepatitis C and have to face a life with liver disease if unrecognised," it said.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.